/Investor DB

Medicxi — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

SUTROVAX, INC.sutrovax.comNASDAQ: PCVXMar 2020

Vaxcyte is a biotech company developing vaccines to treat or prevent serious infectious diseases.

BiotechDeep TechHealthtechSouth San Francisco, US

Grant Pickering(Chief Executive Officer, Director and Co-Founder)Jeff Fairman(Vice President of Research and Co-Founder)Ashish Khanna(Executive Officer)

BoardTracy Saxton(Director)William Newell(Director)Kurt von Emster(Director)in

Board seatMoncef Slaoui· per SEC Form D

Co-investorsAbingworthCTI Life Sciences Fund L.P.Foresite CapitalFrazier Life SciencesJanus Henderson InvestorsLongitude Capital+4 more

SynOx Therapeutics Ltdsynoxtherapeutics.comin𝕏Nov 2020

SynOx Therapeutics develops emactuzumab, a monoclonal antibody treatment for tenosynovial giant cell tumours (TGCT) and macrophage-mediated diseases.

BiotechHealthtechMedical Devices

Ray Barlow(Chief Executive Officer)in

Co-investorsHealthCapBioqube VenturesForbionGimvRed Tree Venture

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Palladio Biosciences

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.